phMRI: Methodological considerations for mitigating potential confounding factors

Frontiers in Neuroscience

Volumn 9, Issue APR, 2015, Pages

  Bourke, Julius H ^a   Wall, M B ^b,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN RECEPTOR; CATECHOL METHYLTRANSFERASE; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; OXYGEN; PLACEBO;

ARTERIAL SPIN LABELING; BLOOD VESSEL REACTIVITY; BOLD SIGNAL; BRAIN REGION; CARDIOVASCULAR PARAMETERS; CELL ACTIVITY; CLINICAL TRIAL (TOPIC); CONDUCTANCE; CONFOUNDING VARIABLE; DNA POLYMORPHISM; DRUG EFFECT; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGICAL PROCEDURES; ENZYMATIC DEGRADATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PHARMACOLOGICAL MAGNETIC RESONANCE IMAGING; RELATIVE DENSITY; SHORT SURVEY; SIGNAL NOISE RATIO; SPIN LABELING; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84928671887     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00167     Document Type: Short Survey

References (50)

1. Aguirre, G.K., Detre, J.A., Zarahn, E., and Alsop, D.C. (2002). Experimental design and the relative sensitivity of BOLD and perfusion fMRI. Neuroimage 15(3): 488-500.
2. Amenta, F., Barili, P., Bronzetti, E., Felici, L., Mignini, F., and Ricci, A. (2000). Localization of dopamine receptor subtypes in systemic arteries. Clin Exp Hypertens 22(3): 277-288.
3. Anderson, I. M., Clark, L., Elliott, R., Kulkarni, B., Williams, S.R., and Deakin, J.F. (2002). 5-HT(2C) receptor activation by m-chlorophenylpiperazine detected in humans with fMRI. Neuroreport 13(12): 1547-1551.
4. Bandettini, P.A., and Wong, E.C. (1997). A hypercapnia-based normalization method for improved spatial localization of human brain activation with fMRI. NMR Biomed 10(4-5): 197-203.
5. Bendlin, B.B., Trouard, T.P., and Ryan, L. (2007). Caffeine attenuates practice effects in word stem completion as measured by fMRI BOLD signal. Hum Brain Mapp 28(7): 654-662.
6. Bifone, A. and Gozzi, A. (2011). Functional and pharmacological MRI in understanding brain function at a systems level. Curr Top Behav Neurosci 7: 323-357.
7. Bloom, A.S., Hoffmann, R.G., Fuller, S.A., Pankiewicz, J., Harsch, H.H., and Stein, E.A. (1999). Determination of drug-induced changes in functional MRI signal using a pharmacokinetic model. Hum Brain Mapp 8(4): 235-244.
8. Breiter, H.C., Gollub, R.L., Weisskoff, R.M., Kennedy, D.N., Makris, N., Berke, J.D., Goodman, J.M., Kantor, H.L., Gastfriend, D.R., Riorden, J.P., Mathew, R.T., Rosen, B.R., and Hyman, S.E. (1997). Acute effects of cocaine on human brain activity and emotion. Neuron 19(3): 591-611.
9. Brunye, T. T., Mahoney, C.R., Rapp, D.N., Ditman, T., and Taylor, H.A. (2012). Caffeine enhances real-world language processing: evidence from a proofreading task. J Exp Psychol Appl 18(1): 95-108.
10. Buxton, R. B., Wong, E.C. and Frank, L.R. (1998). Dynamics of blood flow and oxygenation changes during brain activation: the balloon model. Magn Reson Med 39(6): 855-864.
11. Carhart-Harris, R. L., Wall, MB., Erritzoe, D., Kaelen, M., Ferguson, B., De Meer, I., Tanner, M., Bloomfield, M., Williams, T.M., Bolstridge, M., Stewart, L., Morgan, C.J., Newbould, R.D., Feilding, A., Curran, H.V., and Nutt, D.J. (2014). The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories. Int J Neuropsychopharmacol 17(4): 527-540.
12. Chen, Y. C., Choi, J.K., Andersen, S.L., Rosen, B.R. and Jenkins, B.G. (2005). Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging. Psychopharmacology (Berl) 180(4): 705-715.
13. Chen, Y. I., Choi, J.K., Xu, H., Ren, J., Andersen, S.L., and Jenkins, B.G. (2010). Pharmacologic neuroimaging of the ontogeny of dopamine receptor function. Dev Neurosci 32(2): 125-138.
14. Choi, J. K., Chen, Y.I., Hamel, E., and Jenkins, B.G. (2006). Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine mediated neurovascular coupling. Neuroimage 30(3): 700-712.
15. Choi, J. K., Mandeville, J.B. Chen, Y.I., Grundt, P., Sarkar, S.K., Newman, A.H., and Jenkins, B.G. (2010). Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists. Psychopharmacology (Berl) 212(1): 59-72.
16. Cohen, E. R., Ugurbil, K., and Kim, S.G. (2002). Effect of basal conditions on the magnitude and dynamics of the blood oxygenation level-dependent fMRI response. J Cereb Blood Flow Metab 22(9): 1042-1053.
17. Cole, D.M., Smith, S.M., and Beckmann, C.F. (2010). Advances and pitfalls in the analysis and interpretation of resting-state FMRI data. Front Syst Neurosci 4: 8.
18. Davis, T.L., Kwong, K.K., Weisskoff, R.M., and Rosen, B.R. (1998). Calibrated functional MRI: mapping the dynamics of oxidative metabolism. Proc Natl Acad Sci USA 95(4): 1834-1839.
19. Deakin, J.F., Lees, J., McKie, S., Hallak, J.E., Williams, S.R., and Dursun, S.M. (2008). Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. Arch Gen Psychiatry 65(2): 154-164.
20. Diukova, A., Ware, J., Smith, J.E., Evans, C.J., Murphy, K., Rogers, P.J., and Wise, R.G. (2012). Separating neural and vascular effects of caffeine using simultaneous EEG-FMRI: differential effects of caffeine on cognitive and sensorimotor brain responses. Neuroimage 62(1): 239-249.
21. Dixon, A.L., Prior, M., Morris, P.M. Shah, Y.B., Joseph, M.H. and Young, A.M. (2005). Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 48(2): 236-245.
22. Friston, K.J., Mechelli, A., Turner, R., and Price, C.J. (2000). Nonlinear responses in fMRI: the Balloon model, Volterra kernels, and other hemodynamics. Neuroimage 12(4): 466-477.
23. Glover, G.H., Li, T.Q., and Ress, D. (2000). Image-based method for retrospective correction of physiological motion effects in fMRI: RETROICOR. Magn Reson Med 44(1): 162-167.
24. Hariri, A.R., and Weinberger, D.R. (2003). Imaging genomics. Br Med Bull 65: 259-270.
25. Hoge, R. D., Atkinson, J., Gill, B., Crelier, G.R., Marrett, S., and Pike, G.B. (1999). Linear coupling between cerebral blood flow and oxygen consumption in activated human cortex. Proc Natl Acad Sci USA 96(16): 9403-9408.
26. Honey, G., and Bullmore, E. (2004). Human pharmacological MRI. Trends Pharmacol Sci 25(7): 366-374.
27. Hyder, F., Rothman, D.L. and Shulman, R.G. (2002). Total neuroenergetics support localized brain activity: implications for the interpretation of fMRI. Proc Natl Acad Sci USA 99(16): 10771-10776.
28. Iannetti, G.D., and Wise, R.G. (2007). BOLD functional MRI in disease and pharmacological studies: room for improvement? Magn Reson Imaging 25(6): 978-988.
29. Jenkins, B.G. (2012). Pharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain. Neuroimage 62(2): 1072-1085.
30. Logothetis, N.K., Pauls, J., Augath, M., Trinath, T., and Oeltermann, A. (2001). Neurophysiological investigation of the basis of the fMRI signal. Nature 412(6843): 150-157.
31. Mathew, R.J., and Wilson, W.H. (1985). Caffeine induced changes in cerebral circulation. Stroke 16(5): 814-817.
32. Mattay, V. S., Goldberg, T.E., Fera, F., Hariri, A.R., Tessitore, A., Egan, M.F., Kolachana, B., Callicott, J.H., and Weinberger, D.R. (2003). Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100(10): 6186-6191.
33. McKie, S., Del-Ben, C., Elliott, R., Williams, S., del Vai, N., Anderson, I., and Deakin, J.F. (2005). Neuronal effects of acute citalopram detected by pharmacoMRI. Psychopharmacology (Berl) 180(4): 680-686.
34. Mulderink, T.A., Gitelman, D.R., Mesulam, M.M., and Parrish, T.B. (2002). On the use of caffeine as a contrast booster for BOLD fMRI studies. Neuroimage 15(1): 37-44.
35. Murphy, S.E. and Mackay, C.E. (2011). Using MRI to measure drug action: caveats and new directions. J Psychopharmacol 25(9): 1168-1174.
36. Murphy, S.E., Norbury, R., O'Sullivan, U., Cowen, P.J., and Harmer, C.J. (2009). Effect of a single dose of citalopram on amygdala response to emotional faces. Br J Psychiatry 194(6): 535-540.
37. Pattinson, K.T., Rogers, R., Mayhew, S.D., Tracey, I., and Wise, R.G. (2007). Pharmacological FMRI: measuring opioid effects on the BOLD response to hypercapnia. J Cereb Blood Flow Metab 27(2): 414-423.
38. Pfeuffer, J., Adriany, G., Shmuel, A., Yacoub, E., Van De Moortele, P.F., Hu, X., and Ugurbil K., (2002). Perfusion-based high-resolution functional imaging in the human brain at 7 Tesla. Magn Reson Med 47(5): 903-911.
39. Pinel, P., Thirion, B., Meriaux, S., Jobert, A., Serres, J., Le Bihan, D., Poline, J.B. and Dehaene, S. (2007). Fast reproducible identification and large-scale databasing of individual functional cognitive networks. BMC Neurosci 8: 91.
40. Sauter, A., and Rudin, M. (2000). Pharmacological MRI: a nebulous concept. Trends Pharmacol Sci 21(11): 422-423.
41. Shih, Y.Y., Chen, C.C., Shyu, B.C., Lin, Z.J. Chiang, Y.C., Jaw, F.S., Chen, Y.Y. and Chang, C. (2009). A new scenario for negative functional magnetic resonance imaging signals: endogenous neurotransmission. J Neurosci 29(10): 3036-3044.
42. Tayebati, S.K., Lokhandwala, M.F., and Amenta, F. (2011). Dopamine and vascular dynamics control: present status and future perspectives. Curr Neurovasc Res 8(3): 246-257.
43. Upadhyay, J., Anderson, J., Schwarz, A.J. Coimbra, A., Baumgartner, R., Pendse, G., George, E., Nutile, L., Wallin, D., Bishop, J., Neni, S., Maier, G., Iyengar, S., Evelhoch, J.L., Bleakman, D., Hargreaves, R., Becerra, L., and Borsook, D. (2011). Imaging drugs with and without clinical analgesic efficacy. Neuropsychopharmacology 36(13): 2659-2673.
44. van der Zande, F.H., Hofman, P.A., and Backes, W.H. (2005). Mapping hypercapnia-induced cerebrovascular reactivity using BOLD MRI. Neuroradiology 47(2): 114-120.
45. Wesensten, N.J., Belenky, G., Kautz, M.A., Thorne, D.R., Reichardt, R.M. and Balkin, T.J. (2002). Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology (Berl) 159(3): 238-247.
46. Williams, D.S., Detre, J.A., Leigh, J.S., and Koretsky, A.P. (1992). Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci USA 89(1): 212-216.
47. Wise, R.G. and Tracey, I. (2006). The role of fMRI in drug discovery. J Magn Reson Imaging 23(6): 862-876.
48. Zubieta, J.K., Heitzeg, M.M., Smith, Y.R., Bueller, J.A., Xu, K., Xu, Y., Koeppe, R.A., Stohler, C.S., and Goldman, D. (2003). COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299(5610): 1240-1243.
49. Zuo, X.-N., Anderson, J.S., Bellec, P., Birn, R.M., Biswal, B.B., Blautzik, J., Milham, M.P. (2014). An open science resource for establishing reliability and reproducibility in functional connectomics. Scientific Data, 1, 140049. doi:10.1038/sdata.2014.49
50. Zuo, X.-N, and Xing, X.-X. (2014) Test-retest reliabilities of resting-state FMRI measurements in human brain functional connectomics: A systems neuroscience perspective. Neuroscience & Biobehavioral Reviews 45, 100-118.